edgepedia

All articles A–Z

519,064 articles

Viral culture

Viral culture is a laboratory method that propagates viruses in susceptible host cells, embryonated eggs, or organoids, producing viable isolates and titers for diagnosis and vaccine manufacture.

Viral disease

A viral disease, also called a viral infection, is an illness caused by a virus, ranging from measles and influenza to persistent infections such as HIV.

Viral envelope

Viral envelope: host-derived lipid bilayer around some viruses, studded with viral glycoproteins (HIV gp120/gp41, influenza HA) acquired by budding; mediates attachment and fusion but increases sensitivity to heat, dryness, and disinfectants.

Viral evolution

Viral evolution: change in virus populations driven by mutation, recombination, reassortment, selection, and drift. RNA viruses mutate at 10^-6 to 10^-4 per base per infection; quasispecies dynamics and reassortment drive influenza and HIV variation.

Viral Genes

Viral genes are the DNA or RNA coding segments of a virus genome. Viral genes often overlap, with overprinting producing de novo proteins from alternative reading frames, a key source of novelty and pathogenicity.

Viral Genome

Viral genome: the DNA or RNA a virus packages and replicates, ranging from ~2 kb circoviruses to ~2.5 Mb pandoraviruses, spanning seven Baltimore-style replication classes, quasispecies diversity, and metagenomic discovery.

Viral genome strategies

A viral genome strategy is the combination of nucleic acid type, strandedness, polarity, and segmentation a virus uses to replicate its genome and produce its proteins.

Viral helicases

Viral helicases are enzymes encoded by virus genomes that use ATP hydrolysis to unwind DNA and RNA during replication, making them attractive targets for antiviral drug development.

Viral hemorrhagic fever

Viral hemorrhagic fever (VHF): febrile syndrome with vascular leak and bleeding caused by arenaviruses, bunyaviruses, filoviruses, and flaviviruses; Ebola CFR about 65%, Marburg up to 88% untreated, mostly supportive care.

Viral hemorrhagic septicemia

Viral hemorrhagic septicemia (VHS, Egtved disease), caused by VHSV, a Novirhabdovirus of fish. Notifiable WOAH-listed disease of freshwater and marine finfish; four genotypes, no treatment or commercial vaccine, not a human health risk.

Viral hepatitis

Viral hepatitis: liver inflammation caused by hepatitis viruses A, B, C, D, and E; A and E typically acute, B, C, D acute or chronic; about 1.3 million deaths in 2024, mostly HBV.

Viral hijacking of translation initiation factors

Viral hijacking of translation initiation factors is how viruses cleave or sequester host factors like eIF4G to shut off cellular translation while translating their own mRNAs.

Viral Hit

Viral Hit (싸움독학, How to Fight) is a 2019 Korean webtoon by Taejun Pak and Kim Junghyun about bullied teen Hobin Yu, who learns fighting from a video channel and streams fights for money. Over 2.2 billion views; adapted into a 2024 anime and a 2026 Netflix Japanese live-action series.

Viral Hit (喧嘩独学) (TV series)

Viral Hit (喧嘩独学, Kenka Dokugaku) TV franchise adapted from Taejun Pak and Kim Junghyun's Korean webtoon: a 12-episode 2024 anime by Okuruto Noboru on Fuji TV/Crunchyroll and a 6-episode 2026 Netflix live-action drama directed by Hideki Takeuchi.

Viral interference

Viral interference: suppression of one virus's infection or replication by another virus, via interferon responses, receptor competition, or superinfection exclusion; described by Voroshilova's group in the 1960s and used in plant cross-protection.

Viral load testing

Viral load testing measures the amount of virus in a patient's blood, reported as RNA or DNA copies per milliliter, to track infection and treatment response.

Viral marketing

Viral marketing, also known as viral advertising, is a marketing approach that designs campaigns to spread through social media and word-of-mouth, encouraging recipients to pass content to others for exponential reach.

Viral matrix protein M

Viral matrix protein M, also called viral M or membrane protein, is the envelope-inner-face structural protein of enveloped RNA viruses that bridges nucleocapsid to membrane, drives assembly and budding, and includes coronavirus M, influenza M1, RSV M, and retroviral MA.

Viral meningitis

Viral meningitis, also called aseptic meningitis, is inflammation of the brain and spinal cord lining caused by viruses, most often non-polio enteroviruses. Most cases recover within 7 to 10 days; mortality is far lower than bacterial meningitis.

Viral myocarditis

Viral myocarditis is inflammation of the heart muscle caused by a viral infection, most often parvovirus B19 or HHV-6 today, ranging from no symptoms to heart failure and sudden death.

Viral phenomenon

Viral phenomenon: rapid, widespread spread of information, memes, or behaviors through social networks, studied as information diffusion; complex contagion, structural virality, homophily, and prediction of viral cascades.

Viral Plaque Assay

Viral plaque assay (plaque assay, PFU assay): cell culture method counting plaques of dead cells to quantify infectious virus in PFU/mL; developed by d'Herelle (1917) and Dulbecco and Vogt (1952); basis of the PRNT.

Viral pneumonia

Viral pneumonia: lung infection caused by respiratory viruses such as influenza, SARS-CoV-2, RSV, and parainfluenza; treated with antivirals and supportive care, not antibiotics unless bacterial coinfection is suspected.

Viral Pseudotyping

Viral pseudotyping: making chimeric, replication-defective virus particles bearing another virus's envelope glycoproteins (pseudotyped viruses, pseudoviruses), used at BSL-2 for neutralization assays, vaccine and antiviral research, and gene delivery.

Viral replication

Viral replication: how viruses copy their genomes and assemble progeny inside host cells, via the six-step cycle (attachment, penetration, uncoating, replication, assembly, release), Baltimore classes I-VII, reverse transcriptase, and antiviral targeting.

Viral retinitis

Viral retinitis: herpesvirus infection of the retina, mainly acute retinal necrosis (VZV, HSV), progressive outer retinal necrosis, and CMV retinitis in immunocompromised patients; necrotizing, retinal detachment-prone, treated with systemic and intravitreal antivirals.

Viral shunt

Viral shunt, coined by Wilhelm and Suttle (1999): viral lysis of marine microbes releases DOM recycled by bacteria instead of higher trophic levels, causing 20–40% of surface-ocean microbial mortality and about 25% of carbon recycling.

Viral strategies for immune response evasion

Viral strategies for immune response evasion: mechanisms viruses use to block innate sensors (RLRs, cGAS, IFI16), interferon induction and signaling, MHC class I presentation, antibodies, and complement, including latency, antigenic variation, and host-gene mimicry.

Viral V. Acharya

Viral V. Acharya, known as Viral Acharya, is an Indian-American financial economist at NYU Stern and a former Deputy Governor of the Reserve Bank of India.

Viral vector

Viral vectors are lab-modified viruses (AAV, lentivirus, adenovirus) stripped of disease genes to deliver therapeutic DNA; key platforms differ in cargo size, integration, immunogenicity, and clinical use.